The Effect of Exogenous Glucose-Dependent Insulinotropic Polypeptide in Combination With Glucagon-Like Peptide-1 on Glycemia in the Critically Ill

OBJECTIVE: Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) have additive insulinotropic effects when coadministered in health. We aimed to determine whether GIP confers additional glucose lowering to that of GLP-1 in the critically ill. RESEARCH DESIGN AND METH...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Lee, Michael Y., Fraser, Jonathan D., Chapman, Marianne J., Sundararajan, Krishnaswamy, Umapathysivam, Mahesh M., Summers, Matthew J., Zaknic, Antony V., Rayner, Christopher K., Meier, Juris J., Horowitz, Michael, Deane, Adam M.
Formato: Artigo
Idioma:Inglês
Publicado: American Diabetes Association 2013
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3781541/
https://ncbi.nlm.nih.gov/pubmed/23835687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc13-0307
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares